Abstract
The effect of a prickly pear peel extract on cholesterol excretion and plasma and hepatic cholesterol levels in hamsters with induced hypercholesterolemia was investigated. Female and male hamsters were fed for 5 weeks with experimental diets: NC, normal cholesterol diet; HC, hypocholesterolemic diet; HCOp, HC with prickly pear peel extract and HCPh, HC with phytosterols. Male and females hamsters fed HCOp diet increased their neutral fecal sterols (cholesterol + coprastanol) excretion by 77% (p<0.042) and 120% (p<0.003), respectively, compared to counterparts fed HC diet. Plasma total cholesterol was significantly reduced only in male hamsters fed HCPh. The phytosterols content in HCOp diet was almost 5 fold less compared to HCPh, and both treatments have reduced 35% (p<0.0001) hepatic cholesterol compared to hamsters fed the HC diet. Thus, the prickly pear peel extract rich in phytosterols showed a hypocholesterolemic effect. This evidence suggests that the prickly pear byproduct tested herein has potential to be employed as ingredient or supplement to lower cholesterol and prevent cardiovascular diseases.
Keywords: Byproduct, hamster, hypocholesterolemic effect, phytosterol, prickly pear peel.
Graphical Abstract
Current Bioactive Compounds
Title:An Extract from Prickly Pear Peel (Opuntia ficus-indica) Affects Cholesterol Excretion and Hepatic Cholesterol Levels in Hamsters Fed Hyperlipidemic Diets
Volume: 12 Issue: 1
Author(s): Ada K. Milán-Noris, Rocio A. Chavez-Santoscoy, Andrea Olmos-Nakamura, Janet A. Gutiérrez-Uribe and Sergio O. Serna-Saldívar
Affiliation:
Keywords: Byproduct, hamster, hypocholesterolemic effect, phytosterol, prickly pear peel.
Abstract: The effect of a prickly pear peel extract on cholesterol excretion and plasma and hepatic cholesterol levels in hamsters with induced hypercholesterolemia was investigated. Female and male hamsters were fed for 5 weeks with experimental diets: NC, normal cholesterol diet; HC, hypocholesterolemic diet; HCOp, HC with prickly pear peel extract and HCPh, HC with phytosterols. Male and females hamsters fed HCOp diet increased their neutral fecal sterols (cholesterol + coprastanol) excretion by 77% (p<0.042) and 120% (p<0.003), respectively, compared to counterparts fed HC diet. Plasma total cholesterol was significantly reduced only in male hamsters fed HCPh. The phytosterols content in HCOp diet was almost 5 fold less compared to HCPh, and both treatments have reduced 35% (p<0.0001) hepatic cholesterol compared to hamsters fed the HC diet. Thus, the prickly pear peel extract rich in phytosterols showed a hypocholesterolemic effect. This evidence suggests that the prickly pear byproduct tested herein has potential to be employed as ingredient or supplement to lower cholesterol and prevent cardiovascular diseases.
Export Options
About this article
Cite this article as:
K. Milán-Noris Ada, A. Chavez-Santoscoy Rocio, Olmos-Nakamura Andrea, A. Gutiérrez-Uribe Janet and O. Serna-Saldívar Sergio, An Extract from Prickly Pear Peel (Opuntia ficus-indica) Affects Cholesterol Excretion and Hepatic Cholesterol Levels in Hamsters Fed Hyperlipidemic Diets, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666151231183553
DOI https://dx.doi.org/10.2174/1573407212666151231183553 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?
Current Pharmaceutical Design Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Current Medicinal Chemistry Cysteine Proteinases of Trypanosome Parasites Novel Targets for Chemotherapy
Current Drug Targets The Role of Coronary Angioplasty in the Management of Patients with Stable Coronary Artery Disease
Cardiovascular & Hematological Disorders-Drug Targets Editorial [ Has the Time Come for a New Definition of Microalbuminuria? ]
Current Vascular Pharmacology Is Red Meat Required for the Prevention of Iron Deficiency Among Children and Adolescents?
Current Pediatric Reviews Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians?
Current Cardiology Reviews The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Current Indications for Infective Endocarditis Antibiotic Prophylaxis
Infectious Disorders - Drug Targets Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches
Current Topics in Medicinal Chemistry High Density Lipoprotein Associated Paraoxonase1 Activity in Relation to Oxidative Stress in CAD Patients
Current Cardiology Reviews Vinyl Sulfone Containing Parasitic Cysteinyl Protease Inhibitors
Current Bioactive Compounds tPA in the Central Nervous System: Relations Between tPA and Cell Surface LRPs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial [Hot Topic: Cardiovascular Risk and Inflammation: Pathophysiological Mechanisms, Drug Design, and Targets Executive (Guest Editor: Armen Yuri Gasparyan)]
Current Pharmaceutical Design Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?
Current Drug Targets - Cardiovascular & Hematological Disorders Metabolism in Patients with Rheumatoid Arthritis: Resting Energy Expenditure, Physical Activity and Diet-Induced Thermogenesis. Invited Review
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Editorial [Hot Topic (1): Update on Inflammatory Processes Governing Atherosclerotic Plaque Vulnerability and Reperfusion Injury (Guest Editors: Fabrizio Montecucco and Francois Mach)]
Current Pharmaceutical Biotechnology RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery
Mini-Reviews in Medicinal Chemistry Microalbuminuria In Primary Hypertension
Current Hypertension Reviews